Veraxa Biotech Statistics
NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.04+0.01 (+0.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Veraxa Biotech by the numbers
Veraxa Biotech has a market capitalization of $147.1 million based on 141.41M shares outstanding. With trailing EPS of $-0.57, Veraxa Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 83.3% below its 200-day average.
Average daily trading volume is 267.82K shares, or about $278,530 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VRXA valuation vs. peer median
| Metric | VRXA | Peer median | Difference |
|---|---|---|---|
| Market cap | $147.06M | $148.13M | -1% |
| Avg. volume | 267.82K | 831.15K | -68% |
Peer median across 8 companies: BBOT, PRQR, RNA, ELDN, IFRX, ALXO, ORMP, ZNTL.
Valuation
- Market cap
- $147.06M
- EPS (TTM)
- $-0.57
- Shares outstanding
- 141.41M
Price and trading
- Previous close
- 1.03
- Open
- 1.03
- Day range
- 1.03 – 1.06
- 52-week range
- 0.90 – 27.36
- 52-week change
- -90.10%
- Beta
- —
- Volume
- 114.63K
- Average volume
- 267.82K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 147.06M
- Eps
- -0.57
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.36
- Week52 Low
- 0.90
- Avg Volume
- 267.82K
- Shares Outstanding
- 141.41M
- Ma50
- 1.17
- Ma200
- 6.25
- Pct From52w High
- -96.20%
- Pct From52w Low
- 15.56%